Skip to content

Seaport Therapeutics, Inc.

SPTX

CIK 0002042347

← back to feed
Revenue (TTM)
—
Q1 Jun 2026
Net Income (TTM)
—
Q1 Jun 2026
EPS Diluted (TTM)
—
Q1 Jun 2026
Gross Margin
—
Q1 Jun 2026
Operating Margin
—
Q1 Jun 2026
Net Margin
—
Q1 Jun 2026
Free Cash Flow (TTM)
—
Q1 Jun 2026
Cash
$52.91M
Q1 Jun 2026
Total Debt
—
Q1 Jun 2026
Shares Outstanding
53.53M sh
Q1 Jun 2026

Recent filings